LTPZ:NYE-PIMCO 15+ Year U.S. TIPS Index Exchange-Traded Fund (USD)

ETF | Inflation-Protected Bond |

Last Closing

USD 57.87

Change

-0.26 (-0.45)%

Market Cap

N/A

Volume

0.06M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-02 )

Largest Industry Peers for Inflation-Protected Bond

Symbol Name Price(Change) Market Cap
SCHP Schwab U.S. TIPS ETF

-0.06 (-0.11%)

USD 11.61B
STIP iShares 0-5 Year TIPS Bond ETF

-0.01 (-0.01%)

USD 7.76B
TDTT FlexShares iBoxx 3-Year Target..

N/A

USD 1.76B
TIPX SPDR® Bloomberg 1-10 Year TIP..

N/A

USD 1.41B
TDTF FlexShares iBoxx 5-Year Target..

N/A

USD 0.69B
STPZ PIMCO 1-5 Year U.S. TIPS Index..

+0.01 (+0.02%)

USD 0.48B
TIP iShares TIPS Bond ETF

-0.10 (-0.09%)

N/A
TIPZ PIMCO Broad U.S. TIPS Index Ex..

-0.09 (-0.17%)

N/A

ETFs Containing LTPZ

GDMA 2.95 % 0.00 %

N/A

N/A
HRA:CA 0.00 % 0.98 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Inflation-Protected Bond) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.10% 56% F 32% F
Dividend Return 2.86% 56% F 51% F
Total Return 4.96% 22% F 31% F
Trailing 12 Months  
Capital Gain 13.09% 100% F 40% F
Dividend Return 3.50% 67% D+ 47% F
Total Return 16.59% 100% F 39% F
Trailing 5 Years  
Capital Gain -22.65% 11% F 20% F
Dividend Return 13.82% 22% F 50% F
Total Return -8.83% 11% F 19% F
Average Annual (5 Year Horizon)  
Capital Gain -7.74% N/A N/A 10% F
Dividend Return -4.94% N/A N/A 10% F
Total Return 2.80% N/A N/A 57% F
Risk Return Profile  
Volatility (Standard Deviation) 13.60% N/A N/A 68% D+
Risk Adjusted Return -36.33% N/A N/A 9% A-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike